search
Back to results

Does Thiamine Help Vomiting and Nausea in Pregnancy?

Primary Purpose

Hyperemesis Gravidarum

Status
Terminated
Phase
Phase 3
Locations
Israel
Study Type
Interventional
Intervention
thiamine & promethazine
Sponsored by
HaEmek Medical Center, Israel
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hyperemesis Gravidarum focused on measuring nausea, vomiting, pregnancy, thiamine, promethazine, nausea and vomiting in pregnancy

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Pregnant women until 12th week of gestation
  • The women visit the ER because of nausea and vomiting
  • The women didn't received thiamine yet

Exclusion Criteria:

  • Pregnant women over 12th week of gestation
  • Women that received thiamine before
  • women that allergic to the studied drugs

Sites / Locations

  • Gynecologic department, Haemek medical center

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

1. thiamine

2. promethazine

Arm Description

Pregnant women until 12 week of gestation who refer to the ER because of nausea and vomiting and didn't improve after hydration, will receive thiamine IV

Pregnant women until 12 week of gestation who refer to the ER because of nausea and vomiting and didn't improve after hydration, will receive promethazine IV

Outcomes

Primary Outcome Measures

the improvement in nausea and/or vomiting after treatment

Secondary Outcome Measures

Full Information

First Posted
February 18, 2009
Last Updated
June 21, 2015
Sponsor
HaEmek Medical Center, Israel
search

1. Study Identification

Unique Protocol Identification Number
NCT00861523
Brief Title
Does Thiamine Help Vomiting and Nausea in Pregnancy?
Official Title
Comparison Between the Treatment of Thiamine and Promethazine for Improving Vomiting and Nausea in Pregnancy
Study Type
Interventional

2. Study Status

Record Verification Date
June 2015
Overall Recruitment Status
Terminated
Why Stopped
Difficulties in recruiting patients
Study Start Date
February 2009 (undefined)
Primary Completion Date
January 2012 (Actual)
Study Completion Date
January 2012 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
HaEmek Medical Center, Israel

4. Oversight

5. Study Description

Brief Summary
There are different treatments for nausea and vomiting in pregnancy. According to the ACOG recommendations, promethazine is the first line of parenteral treatment after oral treatment had failed. Thiamine is given to prevent wernicke encephalopathy. This research try to find out whether thiamine helps the vomiting and nausea as well, by comparing the response to thiamine and promethazine in women who suffer from nausea and vomiting in pregnancy.
Detailed Description
Research groups: pregnant women eho visit the emergency room for nausea and vomiting in pregnancy, pregnancy age 12 weeks or less After basic examinations and hydration, the women will randomized to thiamine or promethazine treatment. If no improvement is shown, the patient will be treated with the other drug The patients will be interviewed on their current visit and every two weeks until 14th week of gestation The interview includes medical history and details about their illness, other treatments, hospitalization etc.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hyperemesis Gravidarum
Keywords
nausea, vomiting, pregnancy, thiamine, promethazine, nausea and vomiting in pregnancy

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
50 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1. thiamine
Arm Type
Active Comparator
Arm Description
Pregnant women until 12 week of gestation who refer to the ER because of nausea and vomiting and didn't improve after hydration, will receive thiamine IV
Arm Title
2. promethazine
Arm Type
Active Comparator
Arm Description
Pregnant women until 12 week of gestation who refer to the ER because of nausea and vomiting and didn't improve after hydration, will receive promethazine IV
Intervention Type
Drug
Intervention Name(s)
thiamine & promethazine
Intervention Description
thiamine 100 mg IV promethazine 25 mg IV
Primary Outcome Measure Information:
Title
the improvement in nausea and/or vomiting after treatment
Time Frame
2 months after first visit in ER (until 14 week of pregnancy)

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Pregnant women until 12th week of gestation The women visit the ER because of nausea and vomiting The women didn't received thiamine yet Exclusion Criteria: Pregnant women over 12th week of gestation Women that received thiamine before women that allergic to the studied drugs
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Yfat Kadan
Organizational Affiliation
haemek medical center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Gynecologic department, Haemek medical center
City
Afula
Country
Israel

12. IPD Sharing Statement

Learn more about this trial

Does Thiamine Help Vomiting and Nausea in Pregnancy?

We'll reach out to this number within 24 hrs